Issued US Patents

Home >> About >> Issued US Patents

Method for treating psoriasis by administering an anti-IL-12 antibody. Issued, US patent #9409984.
Anti-IL-6 antibodies, compositions, methods and uses. Issued, US patent #9340613.
Anti-TNF antibodies, compositions, methods and uses. Issued, US patent #9321836.
Generation of human de novo pIX phage display libraries. Issued, US patent #9062305.
Method for treating Crohn’s disease by administering an anti-IL-12
antibody. Issued, US patent #8703141.
Anti-Il-6 antibodies. Issued, US patent #8623362.
Anti-TNF antibodies, compositions, methods and uses. Issued, US patent #8603778.
Immunoglobulin cleavage fragments as disease indicators and compositions
for detecting and binding such. Issued, US patent #8501907.
Method for treating psoriasis by administering an anti-IL-12 antibody. Issued, US patent #8329170.
Method for treating psoriatic arthritis by administering an anti-IL-12
antibody. Issued, US patent #8329171.
Anti-TNF antibodies, compositions, methods and uses. Issued, US patent #8241899.
Anti-IL-6 antibodies, compositions, methods and uses. Issued, US patent #8226611.
Toll like receptor 3 antagonists, methods and uses. Issued, US patent #8153583.
Nucleic acids encoding anti-IL-12 antibody. Issued, US patent #8084233.
Anti IL-12 antibodies. Issued, US patent #8080247.
Methods of treating conditions using anti-IL-6 antibodies. Issued, US patent #8067003.
Anti-IL-6 antibodies, compositions, methods and uses. Issued, US patent #7955597.
Anti-IL-12 antibodies and compositions. Issued, US patent #7887807.
Anti-IL-6 antibodies, compositions, methods and uses. Issued, US patent #7833786.
Anti-IL-6 antibody nucleic acid molecules and methods. Issued, US patent #7833755.
Methods of treating vascular inflammatory pathology using anti-TNF
antibodies and fragments thereof. Issued, US patent #7744885.
Anti-TNF antibodies, compositions, methods and uses. Issued, US patent #7820169.
Anti-TNF antibodies, compositions, methods and uses. Issued, US patent #7815909.
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses. Issued, US patent #7718176.
Anti-TNF antibodies, compositions, methods and uses. Issued, US patent #7691378.
Anti-Il-6 antibodies, compositions, methods and uses. Issued, US patent #7612182.
Nucleic acids encoding anti-IL-12 antibodies, and methods of production. Issued, US patent #7560247
Anti-IL-6 antibodies, compositions, methods and Uses. Issued, US patent #7560112.
Anti-TNF antibodies, compositions, methods and uses. Issued, US patent #7521206.
Methods of inhibiting TNF activity in the blood of a patient. Issued, US patent #7425330.
Methods of treating rheumatoid arthritis with anti-TNF antibodies. Issued, US patent #7416729.
Methods of inhibiting or neutralizing TNF in patients with tissue injury. Issued, US patent #7404955.
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses. Issued, US patent #7393662.
Recombinant A2-specific TNF-specific antibodies. Issued, US patent #7374761
Methods of treating psoriasis with anti-TNF antibodies. Issued, US patent #7335358.
Anti-IL-6 antibodies, compositions, methods, and uses. Issued, US patent #7291721.
Method for treating psoriasis by administering an anti-IL-12 antibody. Issued, US patent #7279157.
Recombinant A2-specific TNF-alpha-specific antibodies. Issued, US patent #7276239.
Recombinant A2-specific TNFa-specific antibodies. Issued, US patent #7252823.
Anti-TNF antibodies, compositions, methods and uses. Issued, US patent #7250165.
Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and
uses. Issued, US patent # 7241733.
Anti-TNF antibody fragments. Issued, US patent # 7227003.
Methods for treating cachexia with anti-TNF antibodies. Issued, US patent #7226593.
Methods of treatment of fistulas in Crohn’s disease with anti-TNF
antibodies. Issued, US patent #7223396.
Mammalian EPO mimetic CH1 deleted Mimetibodies, compositions, methods and
uses. Issued, US patent # 7241733.
Anti-TNF antibody fragments. Issued, US patent #7227003.
Methods of treatment of fistulas in Crohn’s disease with anti-TNF
antibodies. Issued, US patent #7223396.
Methods of inhibiting TNF-a in patients with neoplastic disease. Issued, US patent # 7214376.
Methods of treating disseminated intravascular coagulation by multiple
administration of anti-TNF antibodies. Issued, US patent #7204985.
Methods of treating psoriasis with anti-TNF antibodies. Issued, US patent #7192584.
Recombinant anti-TNF-a antibodies. Issued, US patent #7179893.
Methods of treating rheumatoid arthritis by multiple administration of
anti-TNF antibodies. Issued, US patent #7179466.
Methods of inhibiting TNF-a in patients with cancer. Issued, US patent #7169388.
Methods of treating inflammation associated with viral infection with
anti-TNF antibodies. Issued, US patent #7169386.
Anti-IL-12 antibodies and compostion. Issued, US patent #7166285.
Methods of treating joint inflammation with anti-TNF antibodies. Issued, US patent #7166284.
DNA encoding anti-TNF antibodies and peptides. Issued, US patent #7160995.
Methods of inhibiting TNF-α in patients with Crohn’s disease. Issued, US patent #7160543.
Method of treating psoriasis using human anti-TNF antibodies and fragments . Issued, US patent #7160542.
Methods of treating rheumatoid arthritis with anti-TNF antibodies. Issued, US patent #7138118.
Methods for treating sarcoidosis using anti-TNF antibodies and fragments
thereof. Issued, US patent #7135179.
Methods of treating disseminated intravascular coagulation using anti-TNF
antibodies. Issued, US patent #7135178.
Methods for treating systemic lupus erythematosus using anti-TNF antibodies
and fragments thereof. Issued, US patent #7128908.
Methods of treating crohn’s disease with anti-TNF antibodies. Issued, US patent #7128907.
Anti-idiotypic anti-TNF antibodies and related immunoassay methods. Issued, US patent #7101674.
Recombinant A2-specific anti TNF-alpha antibodies. Issued, US patent #7070775.
Nucleic acids encoding IL-12 antibody. Issued, US patent #7063964.
Chimeric immunoglobulin for CD4 receptors. Issued, US patent #7037496.
Anti-TNF antibodies and peptides of tumor necrosis factor. Issued, US patent #6991791.
Anti-IL-12 antibodies and compositions thereof. Issued, US patent #6902734.
Anti-TNF antibodies and peptides of human tumor necrosis factor. Issued, US Patent #6835823.
Method of reducing the immunogenicity of compounds. Issued, US patent #6652863.
Anti-TNF-α antibodies and assays employing anti-TNFα antibodies. Issued, US patent #6284471.
Anti-TNF antibodies and peptides of human tumor necrosis factor. Issued, US patent #6277969.
Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or
fragments thereof, including c7E3. Issued, US patent #5976532.
Methods of treating TNF-α mediated disease using chimeric anti-TNF
antibodies. Issued, US patent #5919452.
DNAs encoding chimeric immunoglobulin light or heavy chains and fragments
thereof having variable regions derived from monoclonal antibody 7E3, and
vectors and host cells comprising same. Issued, US patent #5877006.
Platelet-specific chimeric 7E3 immunoglobulin. Issued, US patent #5770198.
Methods of Treating Rheumatoid Arthritis using Chimeric Anti-TNF
Antibodies. Issued, US patent #5698195.
Methods of Treating TNF-α-mediated Crohn’s Disease using Chimeric Anti-TNF
Antibodies. Issued, US patent #5656272.
Virus-Free in vitro Assay for Anti-HIV Agents. Issued, US patent #4910132.